Phase II multi center study of combination therapy with irinotecan and S-1 for metastatic colorectal cancer

被引：0
|
作者：
Komatsu, Y.
Yuki, S.
Kato, K.
Kato, S.
Nakamura, M.
Tateyarna, M.
Kudo, M.
Akita, H.
Sakata, Y.
Asaka, M.
机构：
[1] Hokkaido Univ, Sapporo, Hokkaido, Japan
[2] Tomakomai Nissyou Hosp, Sapporo, Hokkaido, Japan
[3] Sapporo Hokuyu Hosp, Sapporo, Hokkaido, Japan
[4] Misawa City Hosp, Misawa, Japan
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：199 / 199
页数：1
相关论文
共 50 条
  • [1] Phase I/II study of sequential therapy with irinotecan and S-1 for metastatic colorectal cancer
    T Yoshioka
    S Kato
    M Gamoh
    N Chiba
    T Suzuki
    N Sakayori
    S Kato
    H Shibata
    H Shimodaira
    K Otsuka
    Y Kakudo
    S Takahashi
    C Ishioka
    British Journal of Cancer, 2009, 101 : 1972 - 1977
  • [2] Phase I/II study of sequential therapy with irinotecan and S-1 for metastatic colorectal cancer
    Yoshioka, T.
    Kato, S.
    Gamoh, M.
    Chiba, N.
    Suzuki, T.
    Sakayori, N.
    Kato, S.
    Shibata, H.
    Shimodaira, H.
    Otsuka, K.
    Kakudo, Y.
    Takahashi, S.
    Ishioka, C.
    BRITISH JOURNAL OF CANCER, 2009, 101 (12) : 1972 - 1977
  • [3] Phase II study of combination therapy with S-1 and irinotecan in patients with advanced colorectal cancer
    Goto, A.
    Yamada, Y.
    Yasui, H.
    Kato, K.
    Hamaguchi, T.
    Muro, K.
    Shimada, Y.
    Shirao, K.
    ANNALS OF ONCOLOGY, 2006, 17 (06) : 968 - 973
  • [4] Phase I/II study of sequential combination with irinotecan and S-1 in patients with metastatic colorectal cancer
    Yoshioka, T.
    Kato, S.
    Gamoh, M.
    Suzuki, T.
    Shibata, H.
    Shimodaira, H.
    Otsuka, K.
    Kakudo, Y.
    Takahashi, S.
    Ishioka, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] A phase I/II study of combination therapy of S-1 and irinotecan in patients with previously untreated metastatic or recurrent colorectal cancer
    Choi, Y.
    Kim, T.
    Lee, S.
    Lee, J.
    Chang, H.
    Kim, H.
    Shin, J.
    Lee, J.
    Kang, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] A phase II study of combination therapy with irinotecan and S-1 (IRIS) in patients with advanced colorectal cancer
    Manabu Shiozawa
    Makoto Akaike
    Nobuhiro Sugano
    Kazuhito Tsuchida
    Naoto Yamamoto
    Soichiro Morinaga
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 987 - 992
  • [7] A phase II study of combination therapy with irinotecan and S-1 (IRIS) in patients with advanced colorectal cancer
    Shiozawa, Manabu
    Akaike, Makoto
    Sugano, Nobuhiro
    Tsuchida, Kazuhito
    Yamamoto, Naoto
    Morinaga, Soichiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (05) : 987 - 992
  • [8] A phase I study of combination therapy with S-1 and irinotecan in patients with previously untreated metastatic or recurrent colorectal cancer
    Yoon Hee Choi
    Tae Won Kim
    Sung Sook Lee
    Yong Sang Hong
    Min-Hee Ryu
    Jae-Lyun Lee
    Heung Moon Chang
    Yoon-Koo Kang
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 905 - 912
  • [9] A phase I study of combination therapy with S-1 and irinotecan in patients with previously untreated metastatic or recurrent colorectal cancer
    Choi, Yoon Hee
    Kim, Tae Won
    Lee, Sung Sook
    Hong, Yong Sang
    Ryu, Min-Hee
    Lee, Jae-Lyun
    Chang, Heung Moon
    Kang, Yoon-Koo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (04) : 905 - 912
  • [10] Phase II study of S-1 in combination with irinotecan in patients with advanced colorectal cancer (CRC)
    Komatsu, Y
    Yuuki, S
    Amano, T
    Machida, N
    Ozasa, M
    Kato, T
    Furukawa, S
    Akita, H
    Asaka, M
    Sakata, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 297S - 297S
12345